Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: Role of gut peptides

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages 2227-2235

  Falkén, Ylva ^a   Hellstrom P M ^b   Holst, J J ^c   Naslund E ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LEPTIN; LIPID; OXYNTOMODULIN; PARACETAMOL; PEPTIDE HORMONE; SOMATOSTATIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG ABSORPTION; FEMALE; FOOD; FOOD DRUG INTERACTION; FOOD INTAKE; GASTROINTESTINAL ABSORPTION; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIQUID; MALE; OBESITY; POSTOPERATIVE PERIOD; POSTPRANDIAL STATE; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; SATIETY; SOMATOSTATIN RELEASE; STOMACH BYPASS;

ADULT; BLOOD GLUCOSE; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; HOMEOSTASIS; HUMANS; INSULIN; LEPTIN; MALE; OBESITY; SOMATOSTATIN; TREATMENT OUTCOME;

EID: 79960088798     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-2876     Document Type: Article

References (44)

1. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H 2004 Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683-2693 (Pubitemid 39665322)
2. Hammoud A, Gibson M, Hunt SC, Adams TD, Carrell DT, Kolotkin RL, Meikle AW 2009 Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab 94:1329-1332
3. Adams TD, Hunt SC 2009 Cancer and obesity: effect of bariatric surgery. World J Surg 33:2028-2033
4. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, McLean LD 2004 Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240:416-424 (Pubitemid 39121336)
5. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I 2009 Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248-256.e5
6. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, Castagneto M, Marescaux J 2006 The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 244:741-749 (Pubitemid 44629948)
7. Mingrone G, Nolfe G, Gissey GC, Iaconelli A, Leccesi L, Guidone C, Nanni G, Holst JJ 2009 Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion. Diabetologia 52:873-881
8. Cummings DE, Overduin J, Foster-Schubert KE 2004 Gastric by-pass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 89:2608-2615 (Pubitemid 38766339)
9. le Roux CW, Welbourn R, Werling M, Osborne A, Kokkunos A, Laurenius A, Lönroth H, Fändriks L, Ghatei MA, Bloom SR, Olbers T 2007 Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 246:780-785 (Pubitemid 350035654)
10. Holdstock C, Zethelius B, Sundbom M, Karlsson FA, Eden Engstrom B 2008 Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes (Lond) 32:1640-1646
11. Laferrére B, Swerdlow N, Bawa B, Arias S, Bose M, Oliván B, Teixeira J, McGinty J, Rother KI 2010 Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes. J Clin Endocrinol Metab 95:4072-4076
12. Holst JJ 1982 Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem J 207:381-388 (Pubitemid 13138851)
13. Holst JJ, Christiansen J, Kühl C 1976 The enteroglucagon response to intrajejunal infusion of glucose, triglycerides, and sodium chloride, and its relation to jejunal inhibition of gastric acid secretion in man. Scand J Gastroenterol 11:297-304
14. Orskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ 1994 Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43:535-539 (Pubitemid 24096293)
15. Krarup T, Madsbad S, Moody AJ, Regeur L, Faber OK, Holst JJ, Sestoft L 1983 Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulindependent) diabetics. J Clin Endocrinol Metab 56:1306-1312 (Pubitemid 13055130)
16. Deacon CF, Nauck MA, Meier J, Hücking K, Holst JJ 2000 Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. J Clin Endocrinol Metab 85:3575-3581
17. Hilsted L, Holst JJ 1982 On the accuracy of radioimmunological determination of somatostatin in plasma. Regul Pept 4:13-31
18. Näslund E, Bogefors J, Grybäck P, Jacobsson H, Hellström PM 2000 Gastric emptying: a comparison of scintigraphic, marker dilution and paracetamol absorption assessment techniques. Scand J Gastroenterol 35:375-379 (Pubitemid 30304420)
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419 (Pubitemid 15018832)
20. Wallace TM, Levy JC, Matthews DR 2004 Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495 (Pubitemid 38680001)
21. Isbell JM, Tamboli RA, Hansen EN, Saliba J, Dunn JP, Phillips SE, Marks-Shulman PA, Abumrad NN 2010 The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 33:1438-1442
22. Barker KB, Palekar NA, Bowers SP, Goldberg JE, Pulcini JP, Harrison SA 2006 Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. Am J Gastroenterol 101:368-373 (Pubitemid 43381682)
23. Tiikkainen M, Bergholm R, Vehkavaara S, Rissanen A, Häkkinen AM, Tamminen M, Teramo K, Yki-Järvinen H 2003 Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 52:701-707 (Pubitemid 36323577)
24. Gebhard B, Holst JJ, Biegelmayer C, Miholic J 2001 Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome. Dig Dis Sci 46:1915-1923 (Pubitemid 32844158)
25. Ahima RS 2006 Adipose tissue as an endocrine organ. Obesity (Silver Spring) 14(Suppl 5):242S-249S
26. Orskov C, Wettergren A, Holst JJ 1996 Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day. Scand J Gastroenterol 31:665-670 (Pubitemid 26290929)
27. Holst JJ 2007 The physiology of glucagon-like peptide 1. Physiol Rev 87:1409-1439 (Pubitemid 350041474)
28. Schjoldager BT, Baldissera FG, Mortensen PE, Holst JJ, Christiansen J 1988 Oxyntomodulin: a potential hormone from the distal gut. Pharmacokinetics and effects on gastric acid and insulin secretion in man. Eur J Clin Invest 18:499-503
29. Wynne K, Park AJ, Small CJ, Meeran K, Ghatei MA, Frost GS, Bloom SR 2006 Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial. Int J Obes (Lond) 30:1729-1736 (Pubitemid 44863404)
30. Holst JJ, Pedersen JH, Baldissera F, Stadil F 1983 Circulating glucagon after total pancreatectomy in man. Diabetologia 25:396-399 (Pubitemid 14235463)
31. Brubaker PL 2010 Minireview: update on incretin biology: focus on glucagon-like peptide-1. Endocrinology 151:1984-1989
32. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV 2005 Hyperinsulinemic hypoglycemia with nesidoblastosis after gastric-bypass surgery. N Engl J Med 353:249-254 (Pubitemid 41058324)
33. Vella A, Service FJ 2007 Incretin hypersecretion in post-gastric bypass hypoglycemia - primary problem or red herring? J Clin Endocrinol Metab 92:4563-4565
34. Marsk R, Jonas E, Rasmussen F, Näslund E 2010 Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden. Diabetologia 53:2307-2311
35. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ 2002 Plasma ghrelin levels after diet-induced weight-loss or gastric bypass surgery. N Engl J Med 346:1623-1630 (Pubitemid 34755670)
36. Holdstock C, Engström BE, Ohrvall M, Lind L, Sundbom M, Karlsson FA 2003 Ghrelin and adipose regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 88:3177-3183 (Pubitemid 36877491)
37. Faraj M, Havel PJ, Phélis S, Blank D, Sniderman AD, Cianflone K 2003 Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88:1594-1602 (Pubitemid 36623375)
38. Sundbom M, Holdstock C, Engström BE, Karlsson FA 2007 Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality? Obes Surg 17:304-310
39. Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ 2007 Exaggerated glucagon-like peptide-1 and blunted glucose dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 3:597-601 (Pubitemid 350091417)
40. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E 2004 The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240:236-242 (Pubitemid 38963013)
41. Chia CW, Carlson OD, Kim W, Shin YK, Charles CP, Kim HS, Melvin DL, Egan JM 2009 Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes. Diabetes 58:1342-1349
42. Baldissera FG, Nielsen OV, Holst JJ 1985 The intestinal mucosa preferentially releases somatostatin-28 in pigs. Regul Pept 11:251-262 (Pubitemid 15039935)
43. Troy S, Soty M, Ribeiro L, Laval L, Migrenne S, Fioramonti X, Pillot B, Fauveau V, Aubert R, Viollet B, Foretz M, Leclerc J, Duchampt A, Zitoun C, Thorens B, Magnan C, Mithieuz G, Andreelli F 2008 Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 8:201-211
44. Wang PY, Caspi CK, Chari M, Li X, Light PE, Gutierrez-Juarez R, Ang M, Schwartz GJ, Lam TK 2008 Upper gastrointestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 452:1012-1016 (Pubitemid 351589616)